Trial Profile
Imidapril Attenuates Matrix Metalloproteinase-9 Activity More Efficiently than Losartan in Patients with Acute Myocardial Infarction
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2011
Price :
$35
*
At a glance
- Drugs Imidapril (Primary) ; Losartan
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 07 Mar 2011 New trial record